{
  "trial_id": "NCT00399529",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histologically confirmed HER-2/neu-overexpressing adenocarcinoma of the breast",
      "label": "met"
    },
    {
      "criterion": "age 18 years or older",
      "label": "met"
    },
    {
      "criterion": "able to give informed consent",
      "label": "met"
    },
    {
      "criterion": "stable central nervous system (CNS) disease that has been adequately treated and is not under active treatment allowed",
      "label": "unknown"
    },
    {
      "criterion": "no systemic oral steroids administered within 28 days prior to initiating treatment on protocol",
      "label": "met"
    },
    {
      "criterion": "adequate bone marrow reserve with absolute neutrophil count (ANC) > 1000 and platelets > 100,000",
      "label": "unknown"
    },
    {
      "criterion": "adequate renal function with serum creatinine < 2.0",
      "label": "met"
    },
    {
      "criterion": "adequate hepatic reserve with serum bilirubin < 2.0, aspartate transaminase (AST) and alanine aminotransferase (ALT) < 2X the upper limit of normal, and alkaline phosphatase < 5X the upper limit of normal",
      "label": "unknown"
    },
    {
      "criterion": "adequate cardiac reserve with a cardiac ejection fraction within the lower limit of facility normal by MUGA, or 45% by echocardiogram",
      "label": "met"
    },
    {
      "criterion": "no active major medical or psychosocial problems that could be complicated by study participation",
      "label": "unknown"
    },
    {
      "criterion": "HIV negative",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "histologic documentation of breast adenocarcinoma",
      "label": "not_met"
    },
    {
      "criterion": "cardiac dysfunction documented by an ejection fraction less than the lower limit of the facility normal by multi-gated acquisition (MUGA) scan, or 45% by echocardiogram",
      "label": "unknown"
    },
    {
      "criterion": "symptomatic intrinsic lung disease or extensive tumor involvement of the lungs resulting in dyspnea at rest",
      "label": "not_met"
    },
    {
      "criterion": "history of autoimmune disease as detailed above",
      "label": "not_met"
    },
    {
      "criterion": "systemic oral corticosteroid treatment within 28 days prior to initiating treatment on study",
      "label": "not_met"
    },
    {
      "criterion": "uncontrolled medical problems",
      "label": "unknown"
    },
    {
      "criterion": "evidence of active acute or chronic infection",
      "label": "not_met"
    }
  ],
  "notes": "Patient is a 22yo F with systemic mastocytosis, presenting with flushing and tachycardia. She responded well to IV steroids and diphenydramine.",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT00399529",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}